Batya Many - Infimer Vice President - Finance
| INFR Stock | ILA 10,500 1,400 15.38% |
President
Ms. Batya Many serves as Vice President Finance at Infimer Ltd since January 8, 2017. She also serves as Vice President Finance at Subsidiaries of the Company and is responsible for the risks management at the Company. Her work experience includes the following roles Chief Financial Officer at Sunflower Sustainable Investments Ltd and Independent Financial Services Provider . She holds a Bachelors degree in Accounting and Economics and a Master of Legal Letters degree, both from Bar Ilan University. She is a Certified Chartered Accountant. since 2017.
| Age | 41 |
| Tenure | 8 years |
| Phone | 972 73 700 0266 |
| Web | http://www.infimer.com |
Infimer Management Efficiency
The company has return on total asset (ROA) of (0.3287) % which means that it has lost $0.3287 on every $100 spent on assets. This is way below average. Infimer's management efficiency ratios could be used to measure how well Infimer manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 6 records | PRESIDENT Age | ||
| Ido Lilian | ICL Israel Chemicals | 59 | |
| Ilana Fahima | ICL Israel Chemicals | 57 | |
| Anat TalKtalav | ICL Israel Chemicals | 51 | |
| Kobi Altman | ICL Israel Chemicals | 52 | |
| Miri Mishor | ICL Israel Chemicals | 59 | |
| Ofer Lifshitz | ICL Israel Chemicals | 61 | |
Management Performance
| Return On Asset | -0.33 |
Infimer Leadership Team
Elected by the shareholders, the Infimer's board of directors comprises two types of representatives: Infimer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Infimer. The board's role is to monitor Infimer's management team and ensure that shareholders' interests are well served. Infimer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Infimer's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Moshe Dayan, Chief Executive Officer | ||
| Asaf Tennenbaum, External Director | ||
| Gosta Tixell, Independent Director | ||
| Shirley Behar, External Director | ||
| Avshalom Shilin, Director | ||
| Yuval Tamir, Chairman of the Board, CEO | ||
| Batya Many, Vice President - Finance | ||
| Tal Tamir, Director | ||
| Eliahu Zahavi, Director | ||
| Oren Zahavi, Vice President - Business Development |
Infimer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Infimer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.33 | |||
| Operating Margin | (9.80) % | |||
| Current Valuation | 25.15 M | |||
| Shares Outstanding | 1.06 M | |||
| Shares Owned By Insiders | 14.32 % | |||
| Shares Owned By Institutions | 10.35 % | |||
| Price To Earning | (867.76) X | |||
| Price To Sales | 4,759 X | |||
| Revenue | 378 K | |||
| Gross Profit | (899 K) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Infimer Stock
Infimer financial ratios help investors to determine whether Infimer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Infimer with respect to the benefits of owning Infimer security.